Fresenius Kabi.
company based in Bad Homborg, Germany; offers health products for the critically and chronically ill.
- Reports this week
- 0
- Active events
- 0
- Connections
- 20
What's happening
Earlier this month
One to three months ago
-
Testimony regarding patent practices influences drug pricing within the U.S. pharmaceutical industry.Some support1 report
-
Fresenius Kabi received regulatory approvals from the EMA and FDA for a vedolizumab biosimilar, while excluding commercialization in the Middle East and North Africa.Some support1 report
Gone quiet
No new reports in 90+ days-
Companies ICU Medical, Fresenius Kabi, Baxter, and Codan are noted as key players in a market where Germany holds the largest market share.Some support1 report
-
Fresenius Kabi acquired a majority stake in mAbxience, which subsequently received European Commission approval for its biosimilars.Speculative1 report
-
Fresenius Kabi received an award announcement in Lake Zurich, Illinois.Some support1 report
-
Fresenius Kabi is involved in shaping the future of healthcare across Southeast Asia.Some support1 report
-
Fresenius Kabi, Charles River Laboratories, Intertek, and Gea were listed in a market report profile.Some support1 report
-
Litigation over patents and generics is ongoing, and DOMA Perpetual Capital Management holds 7.5% of Pacira's outstanding shares.Some support2 reports
No events began in the chosen period. Widen it, or reset.
What's reaching Fresenius Kabi
Events traced to Fresenius Kabi, step by step, newest firstAround Fresenius Kabi this week
News at the entities that move Fresenius Kabi most-
FDA StructuralThe DEA opposed a motion before Chief Administrative Law Judge Julius, noting that both agencies lack comprehensive scheduling policies.Moves Fresenius Kabi
-
European Medicines Agency TransactionalGlenn attended a congress in Amsterdam and participated in a panel with an official from the European Medicines Agency.Moves Fresenius Kabi
-
Morgan Stanley OperationalMorgan Stanley increased its price target for SLM Corporation on September 2, 2026.Moves Fresenius Kabi
-
BioPharma StructuralBioPharma business is now part of Nova Biomedical, with John Luck serving as president of the business unit.Moves Fresenius Kabi
-
Middle East OperationalIran oil crisis impacts petrol prices due to choked oil supplies from the Middle East.Moves Fresenius Kabi
-
Spain Shared contextThe Mediterranean is reporting record sea surface temperatures, while regional plans monitor pollution levels in mudflat areas.Moves Fresenius Kabi
Connections
The 8 strongest of 20, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
The FDA granted regulatory approval for a vedolizumab biosimilar manufactured by Fresenius Kabi.
-
European Medicines Agency Transactional
EMA accepted the Marketing Authorization Application (MAA) for the vedolizumab biosimilar product associated with Fresenius Kabi.
-
BioPharma Structural
Fresenius Kabi employs the President of BioPharma, indicating a formal organizational link.
-
Middle East Operational
Fresenius Kabi has excluded the Middle East from its commercialization rights.
-
Spain Shared context
The company maintains operational facilities in Spain as part of its European market presence.
-
Morgan Stanley Operational
Morgan Stanley has issued and reaffirmed an overweight rating on the shares of Fresenius Kabi.
-
North Africa Transactional
Fresenius Kabi has made a business decision to exclude North Africa from its commercialization rights.
-
BOSS Operational
Fresenius Kabi is actively participating as a performer on the BoSS team.
History
Events by the month they beganOctober 2026
1 eventAugust 2026
1 eventShow 1 earlier month
June 2026
6 events- Companies ICU Medical, Fresenius Kabi, Baxter, and Codan are noted as key players in a market where Germany holds the largest market share.
- Fresenius Kabi acquired a majority stake in mAbxience, which subsequently received European Commission approval for its biosimilars.
- Fresenius Kabi received an award announcement in Lake Zurich, Illinois.
- Fresenius Kabi is involved in shaping the future of healthcare across Southeast Asia.
- Fresenius Kabi, Charles River Laboratories, Intertek, and Gea were listed in a market report profile.
- Litigation over patents and generics is ongoing, and DOMA Perpetual Capital Management holds 7.5% of Pacira's outstanding shares.